Cortical thickness and sub-cortical volumes in post-H1N1 narcolepsy type 1: A brain-wide MRI case-control study.
Entorhinal
MRI
Narcolepsy
Post-H1N1
Superior temporal gyrus
Temporal pole
Journal
Sleep medicine
ISSN: 1878-5506
Titre abrégé: Sleep Med
Pays: Netherlands
ID NLM: 100898759
Informations de publication
Date de publication:
17 Feb 2024
17 Feb 2024
Historique:
received:
20
09
2023
revised:
16
02
2024
accepted:
16
02
2024
medline:
4
3
2024
pubmed:
4
3
2024
entrez:
3
3
2024
Statut:
aheadofprint
Résumé
There was more than a 10-fold increase in the incidence of narcolepsy type 1 (NT1) after the H1N1 mass vaccination in 2009/2010 in several countries. NT1 is associated with loss and increase of cell groups in the hypothalamus which may be associated with secondary affected sub-cortical and cortical gray matter. We performed a case-control comparison of MRI-based global and sub-cortical volume and cortical thickness in post-H1N1 NT1 patients compared with controls. We included 54 post-H1N1 NT1 patients (51 with confirmed hypocretin-deficiency; 48 H1N1-vaccinated with Pandemrix®; 39 females, mean age 21.8 ± 11.0 years) and 114 healthy controls (77 females, mean age 23.2 ± 9.0 years). 3T MRI brain scans were obtained, and the T1-weighted MRI data were processed using FreeSurfer. Group differences among three global, 10 sub-cortical volume measures and 34 cortical thickness measures for bilateral brain regions were tested using general linear models with permutation testing. Patients had significantly thinner brain cortex bilaterally in the temporal poles (Cohen's d = 0.68, p = 0.00080), entorhinal cortex (d = 0.60, p = 0.0018) and superior temporal gyrus (d = 0.60, p = 0.0020) compared to healthy controls. The analysis revealed no significant group differences for sub-cortical volumes. Post-H1N1(largely Pandemrix®-vaccinated) NT1 patients have significantly thinner cortex in temporal brain regions compared to controls. We speculate that this effect can be partly attributed to the hypothalamic neuronal change in NT1, including loss of function of the widely projecting hypocretin-producing neurons and secondary effects of the abnormal sleep-wake pattern in NT1 or could be specific for post-H1N1 (largely Pandemrix®-vaccinated) NT1 patients.
Identifiants
pubmed: 38432031
pii: S1389-9457(24)00073-X
doi: 10.1016/j.sleep.2024.02.031
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
81-89Informations de copyright
Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Ole A. Andreassen reports a relationship with Lundbeck that includes: speaking and lecture fees. Ole A. Andreassen reports a relationship with Sunovion that includes: speaking and lecture fees. Ole A. Andreassen reports a relationship with HealthLytix that includes: consulting or advisory. Ingrid Agartz reports a relationship with Lundbeck that includes: speaking and lecture fees. Stine Knudsen-Heier reports a relationship with UCB Pharma that includes: speaking and lecture fees. Stine Knudsen-Heier reports a relationship with AOP Orphan that includes: speaking and lecture fees. Stine Knudsen-Heier reports a relationship with Jazz Pharmaceuticals that includes: speaking and lecture fees. Stine Knudsen-Heier reports a relationship with Lundbeck that includes: speaking and lecture fees. Stine Knudsen-Heier reports a relationship with The Norwegian state that includes: consulting or advisory.